Proinflammatory and anti-inflammatory cytokine profile in pediatric patients with irritable bowel syndrome;Perfil de citocinas proinflamatorias y antiinflamatorias en pacientes pediátricos con síndrome de intestino irritable

Revista de Gastroenterologia de Mexico

Volumn 80, Issue 1, 2015, Pages 6-12

  Vazquez Frias R ^a   Gutierrez Reyes G ^b   Urban Reyes M ^a   Velazquez Guadarrama N ^a   Fortoul Van Der Goes, T I ^b   Reyes Lopez A ^a   Consuelo Sanchez A ^a  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cytokines; Irritable bowel syndrome; Pediatrics; Transforming growth factor beta

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE;

ADOLESCENT; BLOOD; CASE CONTROL STUDY; CHILD; FEMALE; HUMAN; IRRITABLE BOWEL SYNDROME; MALE; MEXICO;

ADOLESCENT; BIOMARKERS; CASE-CONTROL STUDIES; CHILD; CYTOKINES; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MEXICO;

EID: 84944742386     PISSN: 03750906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rgmx.2014.11.001     Document Type: Article

References (43)

1. Rasquin A, di Lorenzo C, Forbes D, et al. Childhood functional gastrointestinal disorders: Child/adolescent. Gastroenterology. 2006;130:1527-37.
2. Castilloux J, Noble A, Faure C. Is visceral hypersensitivity correlated with symptom severity in children with functional gastrointestinal disorders? J Pediatr Gastroenterol Nutr. 2008;46:272-8.
3. Barbara G, Cremon C, de Giorgio R, et al. Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome. Curr Gastroenterol Rep. 2011;13:308-15.
4. Barbara G, Cremon C, Palloti F, et al. Postinfectious irritable bowel syndrome. J Pediatr Gastroenterol Nutr. 2009;48:S95-7.
5. Camilleri M. Evolving concepts of the pathogenesis of irritable bowel syndrome: To treat the brain or the gut. J Pediatr Gastroenterol Nutr. 2009;48:S46-8.
6. Gonsalkorale WM, Perrey C, Pravica V, et al. Interleukin 10 genotypes in irritable bowel syndrome: Evidence for an inflammatory component? Gut. 2003;52:91-3.
7. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology. 2009;136:1979-88.
8. Grover M, Herfarth H, Drossman DA. The functional-organic dichotomy: Post infectious irritable bowel syndrome and inflammatory bowel disease irritable bowel syndrome. Clin Gastroenterol Hepatol. 2009;7:48-53.
9. Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology. 2002;122:1778-83.
10. Törnblom H, Lindberg G, Nyberg B, et al. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology. 2002;123:1972-9.
11. Ohman L, Isaksson S, Lindmark AC, et al. T-cell activation in patients with irritable bowel syndrome. Am J Gastroenterol. 2009;104:1205-12.
12. Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007;132:913-20.
13. Collins SM. Dysregulation of peripheral cytokine production in irritable bowel syndrome. Am J Gastroenterol. 2005;100:2517-8.
14. Dinan TG, Clarke G, Quigley EM, et al. Enhanced cholinergic mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: Role of muscarinic receptors. Am J Gastroenterol. 2008;103:2570-6.
15. Cremon C, Gargano L, Morselli-Labate AM, et al. Mucosal immune activation in irritable bowel syndrome: Genderdependence and association with digestive symptoms. Am J Gastroenterol. 2009;104:392-400.
16. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128:541-51.
17. Van der Veek PP, van den Berg M, de Kroon YE, et al. Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome. Am J Gastroenterol. 2005;100:2510-6.
18. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut. 1999;45 Suppl 2:1143-7.
19. Hua MC, Lai MW, Kuo ML, et al. Decreased interleukin-10 secretion by peripheral blood mononuclear cells in children with irritable bowel syndrome. J Pediatr Gastroenterol Nutr. 2011;52:376-81.
20. Schmulson M, Ortíz O, Santiago-Lomeli M, et al. Frequency of functional bowel disorders among healthy volunteers in Mexico City. Dig Dis. 2006;24:342-7.
21. López-Colombo A, Morgan D, Bravo-González D, et al. The epidemiology of functional gastrointestinal disorders in Mexico: A population-based study. Gastroenterol Res Pract. 2012;2012:6061174, http://dx.doi.org/10.1155/2012/606174.
22. Hotoleanu C, Popp R, Pavel TA, et al. Genetic determination of irritable bowel syndrome. World J Gastroenterol. 2008;14:6636-40.
23. Spiller RC, Jenkins D, Thornles JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000;47:804-11.
24. Matricon J, Meleine M, Gelot A, et al. Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther. 2012;36:1009-31.
25. Sartor RB. Cytokines in intestinal inflammation: Pathophysiological and clinical considerations. Gastroenterology. 1994;106:533-9.
26. Ford AC, Talley NJ. Mucosal inflamation as a potential etiological factor in irritable bowel syndrome: A systematic review. J Gastroenterol. 2011;46:421-31.
27. Smith AJ, Humphries SE. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev. 2009;20:43-59.
28. Saavedra Y, Vergara P. Hypersensitivity to ovoalbumin induces chronic intestinal dysmotility and increases the number of intestinal mast cells. Neurogastroenterol Motil. 2005;17:112-22.
29. Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011;140:1756-67.
30. Scully P, McKernan D, Keohane J, et al. Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol. 2010;105:2235-43.
31. Karlsson H, Larsson P, Wold AE, et al. Pattern of cytokine responses to Gram-positive and Gram-negative commensal bacteria is profoundlychanged when monocytes differentiate into dendritic cells. Infect Immun. 2004;72:2671-8.
32. Collins SM. The immunomodulation of enteric neuromuscular function: Implications for motility and inflammatory disorders. Gastroenterology. 1996;111:1683-99.
33. Schmulson M, Chey WD. Abnormal immune regulation and low-grade inflammation in IBS: Does one size fit all? Am J Gastroenterol. 2012;107:273-5.
34. Ishijara S, Tada Y, Fukuba N, et al. Pathogenesis of irritable bowel syndrome-review regarding associated infection and immune activation. Digestion. 2013;87:2404-3211.
35. Schmulson M, Pulido-London D, Rodriguez O, et al. Lower serum IL-10 is an independent predictor of IBS among volunteers in Mexico. Am J Gastroenterol. 2012:107:747-53.
36. Chang L, Adeyemo M, Karagiannidis L, et al. Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol. 2012;107:262-72, doi: 10.1038/ajg.2011.423.
37. Liebregts T, Adam B, Bredack Ch, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007;132:913-20.
38. Scully P, McKernan DP, Keohane J, et al. Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol. 2010;105:2235-43.
39. Kindt S, van Oudenhove L, Broekaert D, et al. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil. 2009;21:389-98.
40. Schmulson M, Pulido-London D, Rodríguez O, et al. IL-10 and TNF-α polymorphisms in subjectswith irritable bowel syndrome in Mexico. Rev Esp Enferm Dig. 2013;105:392-9.
41. Gebhardt T, Lorentz A, Detmer F, et al. Growth, phenotype and function of human intestinal mast cells are tightly regulated by transforming growth factor beta1. Gut. 2005;54: 928-34.
42. Gambino R, Bo S, Signorile A, et al. Comparision of two immunometric assays to measure tumor necrosis factor-alpha in human serum. Clin Chim Acta. 2006;364:349-53.
43. Dixon D, Meng H, Goldberg R, et al. Stress and body mass index each contributes independently to tumor necrosis factora production in prepubescent Latino children. J Pediatr Nurs. 2009;244:378-88.